The Institute has a number of free resources available for all our stakeholders. A few examples are listed below.
The SRA is purpose built to speed up multiple steps in the Systematic Review (SR) process. It is freely available for anyone in the world to use. Our current tools:
- Word Frequency Analyser - helps determine which words you should use to construct and refine a search strategy
- Polyglot – Translates search strategies across databases
- Deduplicator - Eliminates duplicate articles for faster screening
- SRA-Helper – Assist citation screening in Endnote using hot-key scripts. Assists with finding full-text articles in PubMed and GoogleScholar.
- RevMan Replicant (Login required) - Automatically generates text for the ‘Results’ section of your meta-analysis from a RevMan file.
- SearchRefiner - A tool that graphically displays the performance of individual words in a search. This allows the removal of poor performing words to help create highly precise searches.
- Disputatron - A tool that detects screening disagreements and decisions (include or exclude) between reviewers. This makes resolving those disagreements easier and much faster.
Our current tools are being continually reviewed and refined with additional tools being developed. The SRA is a modular design which means the tools can be incorporated into existing SR workflows and combined with other automation tools.
Contact us to suggest improvements or report problems on our feedback page.
Abstracts of systematic reviews are very important, as some readers cannot access the full paper, such that abstracts may be the only option for gleaning research results. This can be because of a pay wall, low Internet download capacity, or if the full article is only available in a language not understood by the reader. Readers in countries where English is not the primary language may have access to an abstract translated to their own language, but not to a translated full text.
The PRISMA Statement gives some guidance for abstracts, closely linked to commonly used headings in structured abstracts. After observing that the quality of abstracts of systematic reviews is still poor, we decided to develop an extension to the PRISMA Statement to provide additional guidance on writing abstracts for systematic reviews. We also wanted to provide a checklist enabling the items suggested to fit into any set of headings mandated by a journal or conference submission.
TIDieR (Template for Intervention Description and Replication)
The quality of description of interventions in publications is poor. However without details of the intervention, clinicians cannot use effective interventions in practice and other researchers cannot replicate, build upon or reliably synthesis findings.
With the objective of improving the completeness of reporting, and ultimately the replicability, of interventions, a reporting guideline was developed. The reporting checklist is entitled TIDieR (Template for Intervention Description and Replication). It is an extension of item 5 of the CONSORT 2010 statement and item 11 of the SPIRIT 2013 statement
A tool to guide you through completing each of the TIDieR Checklist items and produce a document which summarises your intervention is now available.
- E-Learning module Helping Patients Make Informed Decisions: Communicating benefits and risks.
- E-Learning module (GP version) Helping Patients Make Informed Decisions: Communicating benefits and harms
- for RACCGP members, there’s a version available through RACGP’s GP Learning as an accredited activity which enables QI and CPD points to be earnt for completing it
- Short videos for clinicians on shared decision making:
- Patient decision aids for acute bronchitis, sore throat, and middle ear infection
Videos on shared decision making and acute respiratory infection’
This is a database of learning resources for teaching EBHC (Evidence-Based Health Care). There are resources for the public, students and professionals.
The CriSTAL tool (Criteria for Screening and Triaging to Appropriate aLternative care) has been developed and validated for older people aged 65+ years either in residential aged care facilities or hospitals. Some of its components have been used for older patients living in the community and visiting their primary care practitioner. Only one study in the USA has applied it to people aged 55+ years. For a list of free resources for researchers and clinicians interested in reducing prognostic uncertainty for their older patients, please visit the CriSTAL website.
MASCoT is a clinical trial enrolment and randomization software developed at the Institute for Evidence-Based Healthcare, Bond University. MASCOT is currently on version v1.2.
Functionality of version 1.2:
Permuted Block randomization for the purpose of stratifying patients.
Allocation Concealment Functionality
Open-label, single blind (patient blinded) or double-blinded trial (clinician and patient blinded)
Contact us for more information or to use the software for your next trial.